MNKD:FROM BOA :The company finished Q1 quarter with a cash balance of $121 million, which was replenished by the $50.0 million milestone payment from Sanofi for the Afrezza deal; however, given its current burn rate and debt, MannKind will probably have to raise additional capital in the coming quarters unless Afrezza trends improve significantly in the near term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.